AIXC
AIXC
NASDAQ · Biotechnology

Aixcrypto Holdings Inc

$1.34
+0.04 (+2.68%)
As of May 16, 2:32 AM ET ·
Financial Highlights (FY 2026)
Revenue
25.07M
Net Income
-2,556,338,487
Gross Margin
13.6%
Profit Margin
-374.3%
Rev Growth
D/E Ratio
0.01
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 13.6% 45.4% 45.4% 45.4%
Operating Margin -445.4% -8.5% -7.7% -8.6%
Profit Margin -374.3% -7.5% -6.9% -7.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 25.07M 987.4K 951.3K 938.4K
Gross Profit 3.42M 448.3K 431.9K 426.1K
Operating Income -111,646,580 -84,408 -72,927 -80,547
Net Income -2,556,338,487 -74,062 -66,038 -67,407
Gross Margin 13.6% 45.4% 45.4% 45.4%
Operating Margin -445.4% -8.5% -7.7% -8.6%
Profit Margin -374.3% -7.5% -6.9% -7.2%
Rev Growth +23.6% +13.9% +9.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 65.7K 2.34M 2.31M 2.07M
Total Equity 12.88M 2.22M 2.59M 2.41M
D/E Ratio 0.01 1.06 0.89 0.86
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -2,086,380,232 -123,235 -109,691 -102,490
Free Cash Flow -44,936 -40,091 -30,740